PRESS RELEASES

Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
November 2, 2021
Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
September 8, 2020
Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
August 4, 2020

1
2
3
4

MEDIA

NEWS

September 30, 2019
ProstateCancerNewsToday.com
Focal Therapy, AuroLase, Shows Good Safety and Potential Effectiveness in Pilot Clinical Trial Learn more
September 3, 2019
MedicalDeviceDaily.com
Nanospectra Biosciences sees publication of positive results with Aurolase therapy Learn more

1
2
3
4
5
6

BLOG HEADLINE

No items found